pentobarbital will reduce the level or outcome of ethotoin by influencing hepatic enzyme CYP2C9/10 metabolism. Use Caution/Keep track of.
pentobarbital will decrease the level or outcome of conivaptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will minimize the extent or impact of vincristine liposomal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.
Caution when discontinuing CYP3A4 inducers that are coadministered with benzhydrocodone (prodrug of hydrocodone); plasma concentrations of hydrocodone may well boost and can result in most likely lethal respiratory melancholy.
Watch Intently (1)pentobarbital will reduce the extent or effect of osilodrostat by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the level or influence of quetiapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
benzhydrocodone/acetaminophen and pentobarbital both increase sedation. Avoid or Use Alternate Drug. Restrict use to people for whom choice cure selections are inadequate
pentobarbital will lessen the level or effect of nelfinavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will minimize the level or effect of eltrombopag by impacting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.
pentobarbital will decrease the extent or influence of oliceridine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an read more eye on. If coadministration with a CYP3A4 inducer is critical, consider raising oliceridine dose right up until stable drug effects are realized; check for indications of opioid withdrawal.
When the buprenorphine dose is insufficient and the CYP3A4 inducer can not be lowered or discontinued, changeover the individual again into a buprenorphine formulation that allows dose adjustments.
pentobarbital will decrease the extent or outcome of osilodrostat by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the level or outcome of ketoconazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.
pentobarbital will minimize the extent or effect of sulfamethoxazole by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unidentified.